Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul 18:4:189.
doi: 10.3389/fonc.2014.00189. eCollection 2014.

Animal models in osteosarcoma

Maria V Guijarro  1 , Steven C Ghivizzani  1 , C Parker Gibbs  1
Affiliations
Review

Animal models in osteosarcoma

Maria V Guijarro et al. Front Oncol. .

Erratum in

  • Corrigendum: Animal models in osteosarcoma.
    Guijarro MV, Ghivizzani CS, Gibbs PC. Guijarro MV, et al. Front Genet. 2015 Jan 14;5:475. doi: 10.3389/fgene.2014.00475. eCollection 2014. Front Genet. 2015. PMID: 25641581 Free PMC article.

Abstract

Osteosarcoma (OS) is the most common non-hematologic primary tumor of bone in children and adults. High-dose cytotoxic chemotherapy and surgical resection have improved prognosis, with long-term survival for non-metastatic disease approaching 70%. However, most OS tumors are high grade and tend to rapidly develop pulmonary metastases. Despite clinical advances, patients with metastatic disease or relapse have a poor prognosis. Toward a better understanding of the molecular pathogenesis of human OS, several genetically modified OS mouse models have been developed and will be reviewed here. However, better animal models that more accurately recapitulate the natural progression of the disease are needed for the development of improved prognostic and diagnostic markers as well as targeted therapies for both primary and metastatic OS.

Keywords: RB; animal models; conditional mouse models; germ-line mouse models; osteosarcoma; p53.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Model of osteoblast differentiation and putative stage of Cre expression is shown.
See this image and copyright information in PMC

References

    1. Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 125(1):229–3410.1002/ijc.24320 - DOI - PMC - PubMed
    1. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 115(7):1531–4310.1002/cncr.24121 - DOI - PMC - PubMed
    1. McKenna RJ, Schwinn CP, Higinbotham NL. Osteogenic sarcoma in children. CA Cancer J Clin (1966) 16(1):26–8 - PubMed
    1. Gorlick R. Current concepts on the molecular biology of osteosarcoma. Cancer Treat Res (2009) 152:467–7810.1007/978-1-4419-0284-9_27 - DOI - PubMed
    1. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment – where do we stand? A state of the art review. Cancer Treat Rev (2014) 40(4):523–3210.1016/j.ctrv.2013.11.006 - DOI - PubMed